Drugmakers Argue Claims In Depo-Provera MDL Are Preempted By Federal Law

( February 4, 2026, 11:47 AM EST) -- PENSACOLA, Fla. — The manufacturers of a long-lasting injectable contraceptive that allegedly caused women to develop intracranial meningiomas, a type of brain tumor, argue in a summary judgment brief that they could not have changed the drug’s warning labels without approval from the U.S. Food and Drug Administration, rendering claims against them preempted by federal law....

Attached Documents

Related Sections